UFF
AVNS icon

USA Financial Formulas’s Avanos Medical AVNS Stock Holding History

USA Financial Formulas’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,448
Closed -$431K – 249
2016
Q3 		$431K Buy
+12,448
New +$436K 0.11% 167

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

USA Financial Formulas's AVNS Position: Q4 2016 in Review

USA Financial Formulas sold out of Avanos Medical (AVNS) in Q4 2016, closing a stake of 12,448 shares — an estimated $431K sold.

USA Financial Formulas first reported a position in AVNS in Q3 2016 and held it in 1 quarter. The position peaked at $431K in Q3 2016. 359 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • USA Financial Formulas reported no remaining Avanos Medical position as of Q4 2016 after selling out during the quarter.
  • USA Financial Formulas sold 12,448 Avanos Medical shares in Q4 2016, an estimated $431K.
  • USA Financial Formulas first reported a position in Avanos Medical in Q3 2016 and held it in 1 quarter.
  • USA Financial Formulas's Avanos Medical position peaked at $431K in Q3 2016.
  • 359 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on USA Financial Formulas's 13F filing for Q4 2016, filed 3 Mar 2017.